SCHEMBL7257319

SCHEMBL7257319

Nc1ccccc1C1=C2C=CC(=N2)C=C2C=CC(=N2)C(c2ccc(CO)cc2)=C2C=CC(=N2)C=C2C=CC1=N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27122607 0.86 ALDH1A1 (0.34) —
SCHEMBL28541499 0.85 ALDH1A1 (0.35) —
SCHEMBL28121892 0.80 ALDH1A1 (0.35) —
SCHEMBL27787590 0.78 KIT (0.31) —
SCHEMBL3992978 0.78 TAAR1 (0.42) —
SCHEMBL7257246 0.77 ALDH1A1 (0.34) —
SCHEMBL3995632 0.76 HSD17B10 (0.38) —
SCHEMBL28809817 0.76 HRH3 (0.35) —
SCHEMBL5050049 0.74 — —
SCHEMBL12076189 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203888-A1 Chromophores WELLCOME TRUST LIMITED, THE (GB) 2003-10-30 — — US disclosed
EP-1294726-A2 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES Catalyst Biomedica Ltd (GB) 2003-03-26 — — EP disclosed
WO-2002000662-A1 IMPROVEMENTS IN AND RELATING TO CHROMOPHORES CATALYST BIOMEDICA LIMITED (GB) 2002-01-03 — — WO disclosed
Send feedback